Evidence map›Paper›PMID 35185113›Full record

ArticleJournal of pediatric gastroenterology and nutrition2022

Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study.

Jake P Mann, Benjamin Jenkins, Samuel Furse, Stuart G Snowden, Anna Alisi, Laura G Draijer, Kylie Karnebeek, Deirdre A Kelly, Bart G Koot, Antonella Mosca and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 3 countries.

Jake P MannInstitute of Metabolic Science.
Benjamin JenkinsCore Metabolomics and Lipidomics Laboratory, Wellcome Trust-MRC institute of Metabolic Science, University of Cambridge, Cambridge.
Samuel FurseCore Metabolomics and Lipidomics Laboratory, Wellcome Trust-MRC institute of Metabolic Science, University of Cambridge, Cambridge.
Stuart G SnowdenCore Metabolomics and Lipidomics Laboratory, Wellcome Trust-MRC institute of Metabolic Science, University of Cambridge, Cambridge.
Anna AlisiResearch Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Laura G DraijerDepartment of Paediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, The Netherlands.
Kylie KarnebeekCentre for Overweight Adolescent and Children's Healthcare (COACH), Department of Pediatrics, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Deirdre A KellyLiver Unit, Birmingham Women's & Children's Hospital, and University of Birmingham, Birmingham, UK.
Bart G KootDepartment of Paediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, The Netherlands.
Antonella MoscaHepatology Gastroenterology and Nutrition, Bambino Gesu Children's Hospital, Rome, Italy.
Camilla SalvestriniDepartment of Paediatric Gastroenterology and Nutrition, Addenbrooke's Hospital.
Indra van MourikLiver Unit, Birmingham Women's & Children's Hospital, and University of Birmingham, Birmingham, UK.
Anita VreugdenhilCentre for Overweight Adolescent and Children's Healthcare (COACH), Department of Pediatrics, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Matthias ZilbauerDepartment of Paediatric Gastroenterology and Nutrition, Addenbrooke's Hospital.
Albert KoulmanCore Metabolomics and Lipidomics Laboratory, Wellcome Trust-MRC institute of Metabolic Science, University of Cambridge, Cambridge.
EU-PNAFLD investigators^
Amsterdam University Medical Centers · NLBambino Gesù Children's Hospital · ITUniversity of Cambridge · GBWellcome Trust · GBAddenbrooke's Hospital · GBBirmingham Women's Hospital · GBMaastricht University · NLMaastricht University Medical Centre · NLRoyal Holloway University of London · GBUniversity of Birmingham · GBWellcome/MRC Institute of Metabolic Science · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M027252/1Biotechnology and Biological Sciences Research Council BB/P028195/1Medical Research Council MR/T001917/1Wellcome Trust 216329
6 · The paper itself

Abstract

objectiveNon-alcoholic fatty liver disease (NAFLD) is an increasingly common condition in children characterised by insulin resistance and altered lipid metabolism. Affected patients are at increased risk of cardiovascular disease (CVD) and children with NAFLD are likely to be at risk of premature cardiac events. Evaluation of the plasma lipid profile of children with NAFLD offers the opportunity to investigate these perturbations and understand how closely they mimic the changes seen in adults with cardiometabolic disease.

methodsWe performed untargeted liquid chromatography-mass spectrometry (LC-MS) plasma lipidomics on 287 children: 19 lean controls, 146 from an obese cohort, and 122 NAFLD cases who had undergone liver biopsy. Associations between lipid species and liver histology were assessed using regression adjusted for age and sex. Results were then replicated using data from 9500 adults with metabolic phenotyping.

resultsMore severe paediatric NAFLD was associated with lower levels of long chain, polyunsaturated phosphatidylcholines (pC) and triglycerides (TG). Similar trends in pC and TG chain length and saturation were seen in adults with hepatic steatosis; however, many of the specific lipids associated with NAFLD differed between children and adults. Five lipids replicated in adults (including PC(36:4)) have been directly linked to death and cardiometabolic disease, as well as indirectly via genetic variants.

conclusionThese findings suggest that, whilst similar pathways of lipid metabolism are perturbed in paediatric NAFLD as in cardiometabolic disease in adults, the specific lipid signature in children is different.

Indexed as

Cardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseAdultChildCross-Sectional StudiesHumansLipidomicsLiverTriglyceridesTriglycerides

Identifiers

PMID35185113
PMCPMC7613028
OpenAlexW4213332871

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.